These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 35016634)

  • 1. Utilizing the MEST score for prognostic staging in IgA nephropathy.
    Haaskjold YL; Bjørneklett R; Bostad L; Bostad LS; Lura NG; Knoop T
    BMC Nephrol; 2022 Jan; 23(1):26. PubMed ID: 35016634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is it possible to predict the evolution of IgAN? Validation of the IgA nephropathy progression calculator and its relationship with MEST-C score in our population.
    Martín-Penagos L; Benito A; Oviedo MV; López Del Moral Cuesta C; Martín López J; Gómez Román J; López-Mejías R; Fernandez-Fresnedo G; Ruíz San Millán JC; Rodrigo Calabia E
    Nefrologia (Engl Ed); 2019; 39(5):523-530. PubMed ID: 30902505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The MEST score provides earlier risk prediction in lgA nephropathy.
    Barbour SJ; Espino-Hernandez G; Reich HN; Coppo R; Roberts IS; Feehally J; Herzenberg AM; Cattran DC; ;
    Kidney Int; 2016 Jan; 89(1):167-75. PubMed ID: 26759049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. To evaluate the utility of Oxford classification in predicting renal outcome in IgA nephropathy patients.
    Saleem N; Nasir H; Anwar F; Aziz M; Khurshid K; Bashir S; Khan A
    Int Urol Nephrol; 2024 Jan; 56(1):345-353. PubMed ID: 37378850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic role of glomerular electron microscopy lesions in IgA nephropathy: "the devil is in the details".
    Terinte-Balcan G; Stancu S; Zugravu A; Capusa C; Radu A; Mircescu G; Stefan G
    J Nephrol; 2023 Nov; 36(8):2233-2243. PubMed ID: 37632668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Automated Prediction of Kidney Failure in IgA Nephropathy with Deep Learning from Biopsy Images.
    Testa F; Fontana F; Pollastri F; Chester J; Leonelli M; Giaroni F; Gualtieri F; Bolelli F; Mancini E; Nordio M; Sacco P; Ligabue G; Giovanella S; Ferri M; Alfano G; Gesualdo L; Cimino S; Donati G; Grana C; Magistroni R
    Clin J Am Soc Nephrol; 2022 Sep; 17(9):1316-1324. PubMed ID: 35882505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of ESRD in IgA Nephropathy Patients from an Asian Cohort: A Random Forest Model.
    Liu Y; Zhang Y; Liu D; Tan X; Tang X; Zhang F; Xia M; Chen G; He L; Zhou L; Zhu X; Liu H
    Kidney Blood Press Res; 2018; 43(6):1852-1864. PubMed ID: 30537719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical implication of crescentic lesions in immunoglobulin A nephropathy.
    Lee MJ; Kim SJ; Oh HJ; Ko KI; Koo HM; Kim CH; Doh FM; Yoo TH; Kang SW; Choi KH; Lim BJ; Jeong HJ; Han SH
    Nephrol Dial Transplant; 2014 Feb; 29(2):356-64. PubMed ID: 24081867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combining clinical features and MEST-C score in IgA nephropathy may be a better determinant of kidney survival.
    Yeter HH; Gonul I; Guz G; Helvaci O; Korucu B; Akcay OF; Derici U; Arinsoy T
    Rom J Intern Med; 2020 Dec; 58(4):209-218. PubMed ID: 32841168
    [No Abstract]   [Full Text] [Related]  

  • 10. Time series changes in pseudo-R2 values regarding maximum glomerular diameter and the Oxford MEST-C score in patients with IgA nephropathy: A long-term follow-up study.
    Kataoka H; Ohara M; Suzuki T; Inoue T; Akanuma T; Kawachi K; Manabe S; Ushio Y; Kawasoe K; Akihisa T; Sato M; Iwasa N; Sawara Y; Honda K; Mochizuki T; Tsuchiya K; Nitta K
    PLoS One; 2020; 15(5):e0232885. PubMed ID: 32379841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A validation study of crescents in predicting ESRD in patients with IgA nephropathy.
    Zhang X; Shi S; Ouyang Y; Yang M; Shi M; Pan X; Lv J; Wang Z; Ren H; Shen P; Wang W; Zhang H; Xie J; Chen N
    J Transl Med; 2018 May; 16(1):115. PubMed ID: 29724226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The correlation analysis between the Oxford classification of Chinese IgA nephropathy children and renal outcome - a retrospective cohort study.
    Wu H; Xia Z; Gao C; Zhang P; Yang X; Wang R; Wang M; Peng Y
    BMC Nephrol; 2020 Jul; 21(1):247. PubMed ID: 32611399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Addition of eGFR and Age Improves the Prognostic Absolute Renal Risk-Model in 1,134 Norwegian Patients with IgA Nephropathy.
    Knoop T; Vågane AM; Vikse BE; Svarstad E; Magnúsdóttir BT; Leh S; Varberg Reisæter A; Bjørneklett R
    Am J Nephrol; 2015; 41(3):210-9. PubMed ID: 25872002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary Matrix Metalloproteinase 7 and Prediction of IgA Nephropathy Progression.
    Yang X; Ou J; Zhang H; Xu X; Zhu L; Li Q; Li J; Xie D; Sun J; Zha Y; Li Y; Tian J; Liu Y; Hou FF
    Am J Kidney Dis; 2020 Mar; 75(3):384-393. PubMed ID: 31606236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical importance of the updated Oxford classification in allograft IgA nephropathy.
    Park S; Go H; Baek CH; Kim YH; Kim YC; Yang SH; Lee JP; Min SI; Ha J; Song EY; Kim YS; Park SK; Lee H; Moon KC
    Am J Transplant; 2019 Oct; 19(10):2855-2864. PubMed ID: 31017369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxford Classification of IgA nephropathy 2016: an update from the IgA Nephropathy Classification Working Group.
    Trimarchi H; Barratt J; Cattran DC; Cook HT; Coppo R; Haas M; Liu ZH; Roberts IS; Yuzawa Y; Zhang H; Feehally J; ;
    Kidney Int; 2017 May; 91(5):1014-1021. PubMed ID: 28341274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Japanese Histologic Classification and T-score in the Oxford Classification system could predict renal outcome in Japanese IgA nephropathy patients.
    Kaihan AB; Yasuda Y; Katsuno T; Kato S; Imaizumi T; Ozeki T; Hishida M; Nagata T; Ando M; Tsuboi N; Maruyama S
    Clin Exp Nephrol; 2017 Dec; 21(6):986-994. PubMed ID: 28349230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of two IgA nephropathy risk-prediction tools using a cohort with a long follow-up.
    Haaskjold YL; Lura NG; Bjørneklett R; Bostad L; Bostad LS; Knoop T
    Nephrol Dial Transplant; 2023 May; 38(5):1183-1191. PubMed ID: 35904322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is there long-term value of pathology scoring in immunoglobulin A nephropathy? A validation study of the Oxford Classification for IgA Nephropathy (VALIGA) update.
    Coppo R; D'Arrigo G; Tripepi G; Russo ML; Roberts ISD; Bellur S; Cattran D; Cook TH; Feehally J; Tesar V; Maixnerova D; Peruzzi L; Amore A; Lundberg S; Di Palma AM; Gesualdo L; Emma F; Rollino C; Praga M; Biancone L; Pani A; Feriozzi S; Polci R; Barratt J; Del Vecchio L; Locatelli F; Pierucci A; Caliskan Y; Perkowska-Ptasinska A; Durlik M; Moggia E; Ballarin JC; Wetzels JFM; Goumenos D; Papasotiriou M; Galesic K; Toric L; Papagianni A; Stangou M; Benozzi L; Cusinato S; Berg U; Topaloglu R; Maggio M; Ots-Rosenberg M; D'Amico M; Geddes C; Balafa O; Quaglia M; Cravero R; Lino Cirami C; Fellstrom B; Floege J; Egido J; Mallamaci F; Zoccali C;
    Nephrol Dial Transplant; 2020 Jun; 35(6):1002-1009. PubMed ID: 30418652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IgA nephropathy clinicopathologic study following the Oxford classification: Progression peculiarities and gender-related differences.
    Riispere Ž; Laurinavičius A; Kuudeberg A; Seppet E; Sepp K; Ilmoja M; Luman M; Kõlvald K; Auerbach A; Ots-Rosenberg M
    Medicina (Kaunas); 2016; 52(6):340-348. PubMed ID: 27932191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.